Skip to main content

RHUMBLINE ADVISERS

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1115418 BOSTON, MA

Position in SPRY

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$580,223
-$273,640 QoQ
Shares Held
72,257
-1.4% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
17 quarters on record
Voting authority Sole 21% Shared 0% None 79%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. SPRY ranks #147 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SPRY

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $580,223 72,257
2025-12-31 $853,863 73,293
2025-09-30 $816,100 81,204
2025-06-30 $1,418,004 81,261
2025-03-31 $877,656 69,766
2024-12-31 $687,469 65,163
2024-09-30 $918,415 63,339
2024-06-30 $561,166 65,942
2024-03-31 $378,691 37,054
2023-12-31 $199,077 36,328
2023-09-30 $137,421 36,355
2023-06-30 $230,687 34,431
2022-03-31 $84,503 24,075
2021-12-31 $141,471 21,242
2021-09-30 $199,729 20,013
2021-06-30 $515,245 16,680
2021-03-31 $575,436 13,189